Debates & Insight Sponsored Disruption and maturity: the future directions for biologics Is the UK’s NHS saving enough from the new wave of biosimilars?
Views & Analysis The UK general election: what pharma wants As the UK election approaches how do the main parties measure up regarding health funding?
Events Partner Content FT Digital Health Summit Europe - London, 27 June 2017 Converting ambition into reality, outcomes and value
Views & Analysis Just how much does the NHS spend on medicines? Confidential discounts and the PPRS pricing system are making it more difficult to arrive at an accurate figure.
News Theresa May backtracks on 'Dementia tax' Parties take out rival ads as social care funding row escalates.
News Pharma underwhelmed by Conservatives' pledges on NHS funding... Prime Minister Theresa May has unveiled the Conservative’s general election manifesto, its range of policies including the promise of £8 billion extra for the NHS – but a rowing back on an
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.